Welcome to The Intel, the Visiopharm Newsletter that brings you our latest news and digital pathology content each month. Here are the highlights of this month:
We are calling on pathology labs to join the Visiopharm Premier Partners program at Pathology Visions
Customer spotlight: Glint Lab’s Journey with Visiopharm Software
Upcoming lectures in our Spatial Biology Masterclass Series
See you at SITC & Pathology Visions!
As always, feel free to get in touch if you have any questions or would like to book a demo. You can also check out our Resources page for the latest guides, posters and webinars.
Unsure how to take the first step into AI-supported biomarker assessments?
Visiopharm wants to help, and we are calling on pathology labs to apply for the opportunity to be selected as a Visiopharm Premier Partner!
If you’re interested in using AI for biomarker assessment, this is your chance to be 1 of just 5 premier labs selected to access our new, fully automated HER2 or PD-L1 analysis solution — at no cost.
Selected Premier Partners will get:
Exclusive access to our APP, platform, and AI experts at no cost for a dedicated study.
A valuable dataset, generated with our APP on your images, for publications, budgeting proposals, and showcasing innovation.
A bridge into AI, ensuring you to stay confident as you take the next step in your digital pathology journey.
Meet Glint Lab, a California-based full stack precision pathology laboratory dedicated to preclinical and early-stage discovery. In our latest interview, Oanh Nguyen, Jason Roberts, and Misagh Naderi, PhD share how they use Visiopharm software to tackle complex challenges in histopathology.
"Visiopharm offers us the unparalleled ability to develop robust custom algorithms for a wide variety of image analysis applications, and to explore spatial data in ways that can not be done with comparable tools." – Jason Roberts, Glint Lab.
